Pathology Services Partnership

  • The Christie NHS Foundation Trust

F14: Notice for changes or additional information

Notice identifier: 2023/S 000-003612

Procurement identifier (OCID): ocds-h6vhtk-03a281

Published 6 February 2023, 3:42pm



Section one: Contracting authority/entity

one.1) Name and addresses

The Christie NHS Foundation Trust

The Christie NHS Foundation Trust, Wilmslow Road

Manchester

M20 4BX

Contact

Ms Diane Sinclair

Email

Diane.Sinclair@nhs.net

Telephone

+44 7748624560

Country

United Kingdom

Region code

UKD3 - Greater Manchester

Internet address(es)

Main address

https://www.christie.nhs.uk

Buyer's address

https://www.christie.nhs.uk


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Pathology Services Partnership

Reference number

DN652962

two.1.2) Main CPV code

  • 85111000 - Hospital services

two.1.3) Type of contract

Services

two.1.4) Short description

Pathology is an essential clinical service, vital to the delivery of efficient and effective

healthcare by preventing, diagnosing, treating and monitoring diseases to keep people as

healthy as possible.

Building on its knowledge and experience, and with the current Joint Venture contract

coming to an end in 2024, The Christie is looking for a commercial partner who matches its

ambitions; who can provide an exceptional, high-quality service that meets the specialist

needs of a comprehensive cancer centre; who can provide investment for the provision of

world class infrastructure; who will embrace the exciting opportunities presented with the colocation of a world leading oncology research centre and; who will provide expert guidance

along with the creativity and drive to deliver a modern, thriving, truly exceptional pathology

service for our patients.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2023/S 000-003320


Section seven. Changes

seven.1.2) Text to be corrected in the original notice

Section number

II.2.4

Place of text to be modified

Description of the procurement

Instead of
Text

The new partnership will need to provide the following:

• A Blood Sciences Essential Services Laboratory (ESL) to achieve rapid turnaround time necessary for clinical pathways and patient flow, ideally on site to facilitate tight turnaround times, and;

• Core Clinical Biochemistry, immunoassay and haematology testing within the ESL to be fully automated, enabling rapid turnaround of test results through pathology workflow efficiencies.

Read
Text

The new partnership will need to provide the following:

• A Blood Sciences Essential Services Laboratory (ESL) to achieve rapid turnaround time necessary for clinical pathways and patient flow, ideally on site to facilitate tight turnaround times, and;

• Core Clinical Biochemistry, immunoassay and haematology testing within the ESL to be fully automated, enabling rapid turnaround of test results through pathology workflow efficiencies.

• Histopathology

• Molecular Diagnostics

• Breast and Gastro-oesophageal Tumour Receptors

• Bereavement and Mortuary.

The Blood Sciences laboratory includes Clinical Biochemistry, Haematology, Blood Transfusion and Stem Cell.

Research and innovation including Blood Sciences Translational Biomarker lab and, Academic Histopathology.

IT infrastructure and digital capability. LIMS infrastructure and integration of Digital Pathology and opportunities to apply Artificial Intelligence/Machine Learning to support diagnostic processes/predictive algorithms across Histopathology and Blood Sciences. Business Intelligence capability to optimise performance monitoring and service workflow/workforce, and demand/capacity modelling.

Exploration of Microbiology and Virology services (currently outsourced).